Cargando…
Analysis of mutations in pncA reveals non-overlapping patterns among various lineages of Mycobacterium tuberculosis
Pyrazinamide (PZA) is an important first-line anti-tuberculosis drug, resistance to which occurs primarily due to mutations in pncA (Rv2043c) that encodes the pyrazinamidase enzyme responsible for conversion of pro-drug PZA into its active form. Previous studies have reported numerous resistance-con...
Autores principales: | Baddam, Ramani, Kumar, Narender, Wieler, Lothar H., Lankapalli, Aditya Kumar, Ahmed, Niyaz, Peacock, Sharon J., Semmler, Torsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854631/ https://www.ncbi.nlm.nih.gov/pubmed/29545614 http://dx.doi.org/10.1038/s41598-018-22883-9 |
Ejemplares similares
-
Author Correction: Analysis of mutations in pncA reveals non-overlapping patterns among various lineages of Mycobacterium tuberculosis
por: Baddam, Ramani, et al.
Publicado: (2018) -
Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea.
por: Lee, K. W., et al.
Publicado: (2001) -
pncA mutations in clinical Mycobacterium tuberculosis isolates from Korea
por: Park, Soon Kew, et al.
Publicado: (2001) -
pncA Large Deletion is the Characteristic of Pyrazinamide-Resistant Mycobacterium tuberculosis belonging to the East Asian Lineage
por: Kim, Na Yung, et al.
Publicado: (2023) -
Genome dynamics and evolution of Salmonella Typhi strains from the typhoid-endemic zones
por: Baddam, Ramani, et al.
Publicado: (2014)